K-numberK242821
Device nameEFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)
ApplicantEver Fortune.Ai, Co., Ltd.
Product codeQAS
Device classClass II
Decision dateFeb 20, 2025
DecisionSubstantially Equivalent
Regulation892.2080
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

EFAI ETTXR is a radiological computer-aided triage and notification software that analyzes chest X-ray images in adults to identify suspected malpositioned endotracheal tubes (ETTs) relative to the carina. It flags cases when the ETT distal tip is assessed as more than 7 cm above the carina, less than 3 cm above it, or below the carina, using deep learning algorithms to provide case-level notifications to PACS/workstations for workflow prioritization. The device is not intended for stand-alone clinical decision-making or to rule out malpositioned ETT.

Technological characteristics

Both the proposed device and predicate (BriefCase, K221330) are AI-based triage software analyzing chest X-rays for malpositioned ETT detection with similar intended uses, user populations, anatomical focus, DICOM image format, and workflow integration. The minor technical difference is that EFAI ETTXR delivers notifications as text-based JSON files rather than with embedded preview images, though both provide case-level outputs for triage purposes without removing or deprioritizing cases.

Test standards cited

IEC 62304:2006/A1:2016 (Medical device software – Software life cycle processes), ISO 14971:2019 (Application of risk management to medical devices), and FDA Guidance documents on premarket submissions for device software functions and cybersecurity in medical devices. Compliance with 21 CFR Part 820.30 design control requirements was demonstrated.

Substantial equivalence argument

EFAI ETTXR and BriefCase share the same intended use (triaging chest radiographs for suspected malpositioned ETTs), identical user populations and anatomical focus, equivalent AI algorithmic approaches, and comparable clinical workflow integration without case removal or deprioritization. Performance validation demonstrated sensitivity and specificity of 0.890 and 0.935 respectively, meeting the 80% performance goal and matching the predicate's performance. The sole technical difference—JSON notification format versus embedded preview images—does not introduce new safety or effectiveness risks since both provide case-level outputs for use with full clinical images.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →